SAPHNELO 300 mg/2mL (Anifrolumab-fnia INJECTION, SOLUTION) 300 mg/2mL

SAPHNELO 300 mg/2mL is an intravenous solution containing anifrolumab-fnia. This medication is used to manage certain autoimmune conditions. Learn more about its uses and effects.

Strength

300 mg/2mL

Pack Size

1 VIAL, GLASS in 1 CARTON (0310-3040-00) / 2 mL in 1 VIAL, GLASS

Manufacturer / TM Owner

AstraZeneca Pharmaceuticals LP

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

SAPHNELO 300 mg/2mL is primarily used for the treatment of autoimmune diseases. It works by targeting specific pathways in the immune system to reduce inflammation and symptoms associated with these conditions. Patients often wonder, 'What is SAPHNELO used for?' This medication is typically prescribed for conditions where the immune system attacks healthy tissues.

Side Effects

Common effects of SAPHNELO 300 mg/2mL may include reactions at the injection site, such as redness or swelling. Some users may experience fatigue or mild flu-like symptoms. These effects vary among individuals and are generally mild to moderate in nature.

Precautions & Warnings

SAPHNELO 300 mg/2mL should be handled with care, following the instructions provided by healthcare professionals. It is important to store the medication properly and use it as directed. Patients with certain medical conditions or allergies should consult their healthcare provider before use.

Avoid Interactions

SAPHNELO 300 mg/2mL may interact with other medications, including those that affect the immune system. It is advisable to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol and certain supplements may also interact with this medication.

Frequently Asked Questions

SAPHNELO is used to treat certain autoimmune conditions by targeting specific immune system pathways.

SAPHNELO is administered intravenously as a solution.

Common side effects may include injection site reactions, fatigue, and mild flu-like symptoms.

SAPHNELO may interact with other medications, so it is important to consult a healthcare provider before combining treatments.

SAPHNELO should be stored according to the instructions provided by the manufacturer to maintain its effectiveness.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.